| scholarly article | Q13442814 |
| P50 | author | Josep Guarro Artigas | Q36591058 |
| P2093 | author name string | Emilio Mayayo | |
| Javier Capilla | |||
| Fabiola Fernández-Silva | |||
| P2860 | cites work | Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America | Q28255282 |
| Disseminated sporotrichosis and Sporothrix schenckii fungemia as the initial presentation of human immunodeficiency virus infection | Q28274476 | ||
| Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest | Q31121317 | ||
| Sporotrichosis. | Q33728578 | ||
| Correlation between in vitro activity of posaconazole and in vivo efficacy against Rhizopus oryzae infection in mice | Q33826450 | ||
| Efficacies of four antifungal agents in experimental murine sporotrichosis | Q35564563 | ||
| Disseminated Sporothix schenckii in a patient with AIDS. | Q36288648 | ||
| Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis | Q37119054 | ||
| Sporotrichosis: an update | Q37798713 | ||
| In vitro antifungal susceptibilities of five species of sporothrix | Q41915091 | ||
| Antifungal therapy in a murine model of disseminated infection by Cryptococcus gattii | Q42154719 | ||
| In vitro activity and in vivo efficacy of posaconazole in treatment of murine infections by different isolates of the Aspergillus terreus complex | Q42582961 | ||
| MICs and minimum fungicidal concentrations of amphotericin B, itraconazole, posaconazole and terbinafine in Sporothrix schenckii | Q43292307 | ||
| Different virulence levels of the species of Sporothrix in a murine model | Q44607554 | ||
| Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test. | Q46039204 | ||
| Disseminated sporotrichosis - clinical case and discussion | Q46558030 | ||
| Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil | Q46715617 | ||
| Sporothrix schenckii meningitis in a farmer with Hodgkin's disease | Q71152031 | ||
| Variants of Sporothrix schenckii with attenuated virulence for mice | Q73863301 | ||
| Successful treatment of a disseminated Sporothrix schenckii infection and in vitro analysis for antifungal susceptibility testing | Q80324467 | ||
| Cutaneous and meningeal sporotrichosis in a HIV patient | Q80552998 | ||
| Disseminated sporotrichosis presenting with granulomatous inflammatory multiple mononeuropathies | Q80595856 | ||
| Disseminated sporotrichosis as a manifestation of immune reconstitution inflammatory syndrome | Q82662302 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sporotrichosis | Q767327 |
| posaconazole | Q906453 | ||
| P304 | page(s) | 2273-2277 | |
| P577 | publication date | 2012-02-13 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Efficacy of posaconazole in murine experimental sporotrichosis | |
| P478 | volume | 56 |
| Q61815416 | An atypical cause of sporotrichosis in a cat |
| Q92025941 | Central Nervous System Infection with Other Endemic Mycoses: Rare Manifestation of Blastomycosis, Paracoccidioidomycosis, Talaromycosis, and Sporotrichosis |
| Q48163292 | Cutaneous Disseminated and Extracutaneous Sporotrichosis: Current Status of a Complex Disease. |
| Q58827586 | Diagnosis and Treatment of Non-European Fungal Infections |
| Q38221100 | Dimorphic fungal osteoarticular infections. |
| Q40187292 | Efficacy of a poly-aggregated formulation of amphotericin B in treating systemic sporotrichosis caused by Sporothrix brasiliensis. |
| Q33611290 | Genetic diversity and antifungal susceptibility profiles in causative agents of sporotrichosis. |
| Q40898822 | In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis |
| Q55511181 | Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. |
| Q44111081 | Modest efficacy of voriconazole against murine infections by Sporothrix schenckii and lack of efficacy against Sporothrix brasiliensis |
| Q35856766 | Molecular Diagnosis of Pathogenic Sporothrix Species. |
| Q38663717 | Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods |
| Q39258185 | Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance |
| Q42281435 | Sporothrix schenckii sensu stricto and Sporothrix brasiliensis Are Differentially Recognized by Human Peripheral Blood Mononuclear Cells. |
| Q34968193 | Sporotrichosis: an overview and therapeutic options |
| Q41662926 | Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine. |
Search more.